British Fertility Society Policy and Practice Committee: Adjuvants in IVF: Evidence for good clinical practice

References

• Aghahosseini, M., Aleyassin, A., Khodaverdi, S., Esfahani, F., Mohammadbeigi, R., Movahedi, S., et al. (2011). Estradiol supplementation during the luteal phase in poor responder patients undergoing in vitro fertilization: a randomized clinical trial. Journal of Assisted Reproduction and Genetics, 28, 785–790.
   PubMed Web of Science ®Google Scholar
• Akhtar, M.A., Sur, S., Raine-Fenning, N., Jayaprakasan, K., Thornton, J.G., & Quenby, S. (2013). Heparin for assisted reproduction. Cochrane Database of Systematic Reviews, 8, CD009452.
   Google Scholar
• Ando, T., Suganuma, N., Furuhashi, M., Asada, Y., Kondo, I., & Tomoda, Y. (1996). Successful glucocorticoid treatment for patients with abnormal autoimmunity on in vitro fertilization and embryo transfer. Journal of Assisted Reproduction and Genetics, 13, 776–781.
   PubMed Web of Science ®Google Scholar
• Asimakopoulos, B., Demirel, C., Felberbaum, R., Waczek, S., Nikolettos, N., Köster, F., et al. (2010). Concentrations of inflammatory cytokines and the outcome in ICSI cycles. In Vivo, 24, 495–500.
   PubMed Web of Science ®Google Scholar
• Azem, F., Many, A., Ben Ami, I., Yovel, I., Amit, A., Lessing, J.B., & Kupferminc, M.J. (2004). Increased rates of thrombophilia in women with repeated IVF failures. Human Reproduction, 19, 368–370.
   PubMed Web of Science ®Google Scholar
• Barad, D., & Gleicher, N. (2006). Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Human Reproduction, 21, 2845–2849.
   PubMed Web of Science ®Google Scholar
• Barad, D., Brill, H., & Gleicher, N. (2007). Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. Journal of Assisted Reproduction and Genetics, 24, 629–634.
   PubMed Web of Science ®Google Scholar
• Bergh, C., Nilsson, L., Hillensjo, T., Borg, T., Wikland, M., & Hamberger, L. (1994). Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertility & Sterility, 62, 113–120.
   PubMed Web of Science ®Google Scholar
• Berker, B., Taskin, S., Kahraman, K., Taskin, E.A., Atabekoglu, C., & Sonmezer, M. (2011). The role of low-molecular-weight heparin in recurrent implantation failure: a prospective, quasi-randomized, controlled study. Fertility & Sterility, 95, 2499–2502.
   PubMed Web of Science ®Google Scholar
• Bongartz, T., Sutton, A.J., Sweeting, M.J., Buchan, I., Matteson, E.L., & Montori, V. (2006). Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA, 295, 2275–2285.
   PubMed Web of Science ®Google Scholar
• Bongartz, T., Warren, F.C., Mines, D., Matteson, E.L., Abrams, K.R., & Sutton, A.J. (2009). Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials. Annals of Rheumatic Diseases, 68, 1177–1183.
   PubMed Web of Science ®Google Scholar
• Boomsma, C.M., Eijkemans, M.J.C, Hughes, E.G., Visser, G.H.A., Fauser, B.C.J.M., & Macklon, N.S. (2006). A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Human Reproduction Update, 12, 673–683.
   PubMed Web of Science ®Google Scholar
• Boomsma, C.M. & Macklon, N.S. (2008). Does glucocorticoid therapy in the peri-implantation period have an impact on IVF outcomes? Current Opinionin Obstetrics and Gynecolology, 20, 249–256.
   PubMed Web of Science ®Google Scholar
• Boomsma, C.M., Keay, S.D., & Macklon, N.S. (2012). Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database of Systematic Reviews, 6, CD005996.
   Google Scholar
• Bosdou, J.K., Venetis, C.A., Kolibianakis, E.M., Toulis, K.A., Goulis, D.G., Zepiridis, L., & Tarlatzis, B.C. (2012). The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Human Reproduction Update, 18, 127–145.
   PubMed Web of Science ®Google Scholar
• Brewer, C., Acharya, S., Thake, F., Tang, T., & Balen, A. (2010). Effect of metformin taken in the ‘fresh’ in vitro fertilization/intracytoplasmic sperm injection cycle upon subsequent frozen embryo replacement in women with polycystic ovary syndrome. Human Fertility, 13, 134–142.
   Web of Science ®Google Scholar
• Carbone, J. (2007). Adverse reactions and pathogen safety of intravenous immunoglobulin. Current Drug Safety, 2, 9–18.
   PubMedGoogle Scholar
• Casson, P.R., Lindsay, M.S., Pisarska, M.D., Carson, S.A., & Buster, J.E. (2000). Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Human Reproduction, 15, 2129–2132.
   PubMed Web of Science ®Google Scholar
• Chamley, L.W., Duncalf, A.M., Mitchell, M.D., & Johnson, P.M. (1998). Action of anticardiolipin and antibodies to beta2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet, 352, 1037–1038.
   PubMed Web of Science ®Google Scholar
• Chang, E.M., Han, J.E., Won, H.J., Kim, Y.S., Yoon, T.K., & Lee, W.S. (2012). Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in vitro fertilization. Journal of Assisted Reproduction and Genetics, 29, 225–230.
   PubMed Web of Science ®Google Scholar
• Check, J.H., Graziano, V., Lee, G., Nazari, A., Choe, J.K., & Dietterich, C. (2004). Neither sildenafil nor vaginal estradiol improves endometrial thickness in women with thin endometria after taking oral estradiol in graduating dosages. Clinicaland Experimental Obstetrics & Gynecology, 31, 99–102.
   PubMedGoogle Scholar
• Chwalisz, K., Winterhager, E., Thienel, T., & Garfield, R.E. (1999). Synergisticrole of nitric oxide and progesterone during the establishment of pregnancyin the rat. Human Reproduction, 14, 542–552.
   PubMed Web of Science ®Google Scholar
• Clarke, D.A., Coulam, C.B., & Stricker, R.B. (2006). Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF). Journal of Assisted Reproduction and Genetics, 23, 1–13.
   PubMed Web of Science ®Google Scholar
• Clark, D.A. (2009). Should anti-TNF-alpha therapy be offered to patients with infertility and recurrent spontaneous abortion? American Journalof Reproductive Immunology, 61, 107–112.
   PubMed Web of Science ®Google Scholar
• Clark, D.A. (2010). Anti-TNF-α therapy in immune-mediated subfertility: state of the art. Journal of Reproductive Immunology, 85, 15–24.
   PubMed Web of Science ®Google Scholar
• Coulam, C.B., Jeyendran, R.S., Fishel, L.A., & Roussev, R. (2006). Multiple thrombophilic gene mutations are risk factors for implantation failure. Reproductive Biomedicine Online, 12, 322–327.
   PubMed Web of Science ®Google Scholar
• Dentali, F., Ageno, W., Rezoagli, E., Rancan, E., Squizzato, A., Middeldorp, S., et al. (2012). Low-dose aspirin for in vitro fertilization or intracytoplasmic sperm injection: a systematic review and a meta-analysis of the literature. Journalof Thrombosis and Haemostasis, 10, 2075–2085.
   PubMed Web of Science ®Google Scholar
• Di Simone, N., Meroni, P.L., de Papa, N., Raschi, E., Caliandro, D., De Carolis, C.S., et al. (2000). Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis & Rheumatism, 43, 140–150.
   PubMed Web of Science ®Google Scholar
• Doldi, N., Persico, P., Di Sebastiano, F., Marsiglio, E., & Ferrari, A. (2006). Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer. Gynecological Endocrinology, 22, 235–238.
   PubMed Web of Science ®Google Scholar
• Duffy, J.M.N., Ahmad, G., Mohiyiddeen, L., Nardo, L.G., & Watson, A. (2010). Growth hormone for in vitro fertilization. Cochrane Database of Systematic Reviews, 1, CD000099.
   Google Scholar
• Eftekhar, M., Aflatoonian, A., Mohammadian, F., & Eftekhar, T. (2013). Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology. Archives of Gynecology and Obstetrics, 287, 1017–1021
   PubMed Web of Science ®Google Scholar
• Elram, T., Simon, A., Israel, S., Revel, A., Shveiky, D., & Laufer, N. (2005). Treatment of recurrent IVF failure and human leukocyte antigen similarity by intravenous immunoglobulin. Reproductive Biomedicine Online, 11, 745–749.
   PubMed Web of Science ®Google Scholar
• Erden, O., Imir, A., Guvenal, T., Muslehiddinoglu, A., Arici, S., Cetin, M., & Cetin, A. (2006). Investigation of the effects of heparin and low molecular weight heparin on E-cadherin and laminin expression in rat pregnancy by immunohistochemistry. Human Reproduction, 21, 3014–3018.
   PubMed Web of Science ®Google Scholar
• Falconer, H., Sundqvist, J., Gemzell-Danielsson, K., von Schoultz, B., D’Hooghe, T.M., & Fried, G. (2009). IVF outcome in women with endometriosis in relation to tumour necrosis factor and anti-Müllerian hormone. Reproductive Biomedicine Online, 18, 582–588.
   PubMed Web of Science ®Google Scholar
• Fanchin, R., Righini, C., Olivennes, F., Taylor, S., de Ziegler, D., & Frydman, R. (1998). Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Human Reproduction, 13, 1968–1974.
   PubMed Web of Science ®Google Scholar
• Fasouliotis, S.J., Spandorfer, S.D., Witkin, S.S., Schattman, G., Liu, H.C., Roberts, J.E., & Rosenwaks, Z. (2004). Maternal serum levels of interferon-gamma and interleukin-2 soluble receptor-alpha predict the outcome of early IVF pregnancies. Human Reproduction, 19, 1357–1363.
   PubMed Web of Science ®Google Scholar
• Fawzy, M. & El-Refaeey, A.A. (2014). Does combined prednisolone and low molecular weight heparin have a role in unexplained implantation failure? Archives of Gynecology and Obstetrics, 289, 677–680.
   PubMed Web of Science ®Google Scholar
• Feldmeyer, L., Benden, C., Haile, S.R., Boehler, A., Speich, R., French, L.E., & Hofbauer, G.F. (2010). Not all intravenous immunoglobulin preparations are equally well tolerated. Acta Dermato-Venereologica, 90, 494–497.
   PubMed Web of Science ®Google Scholar
• Fluhr, H., Spratte, J., Ehrhardt, J., Steinmuller, F., Licht, P., Zygmunt, M. (2010). Heparin and low-molecular-weight heparins modulate the decidualization of human endometrial stromal cells. Fertility & Sterility, 93, 2581–2587.
   PubMed Web of Science ®Google Scholar
• Fouany, M.R. & Sharara, F.I. (2013). Is there a role for DHEA supplementation in women with diminished ovarian reserve? Journal of Assisted Reproduction and Genetics, 30, 1239–1244.
   PubMed Web of Science ®Google Scholar
• Gelbaya, T.A., Kyrgiou, M., Li, T.C., Stern, C., & Nardo, L.G. (2007). Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis. Human Reproduction Update, 13, 357–364.
   PubMed Web of Science ®Google Scholar
• Geva, E., Amit, A., Lerner-Geva, L., Azem, F., Yovel, I., & Lessing, J.B. (1995). Autoimmune disorders: another possible cause for in-vitro fertilization and embryo transfer failure. Human Reproduction, 10, 2560–2563.
   PubMed Web of Science ®Google Scholar
• Geva, E., Amit, A., Lerner-Geva, L., Yaron, Y., Daniel, Y., Schwartz, T., et al. (2000). Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: a prospective study. American Journal of Reproductive Immunology, 43, 36–40.
   PubMed Web of Science ®Google Scholar
• Girardi, G., Redecha, P., & Salmon, J.E. (2004). Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nature Medicine, 10, 1222–1226.
   PubMed Web of Science ®Google Scholar
• Gorkemli, H., Ak, D., Akyurek, C., Aktan, M., & Duman, S. (2004). Comparison of pregnancy outcomes of progesterone or progesterone + estradiol for luteal phase support in ICSI-ET cycles. Gynecologic and Obstetric Investigation, 58, 140–144.
   PubMed Web of Science ®Google Scholar
• Granato, D., Blum, S., Rössle, C., Le Boucher, J., Malnoë, A., & Dutot, G. (2000). Effects of parenteral lipid emulsions with different fatty acid composition on immune cell functions in vitro. Journal of Parenteraland Enteral Nutrition, 24, 113–118.
   PubMed Web of Science ®Google Scholar
• Griesinger, G., Kolibianakis, E.M., Venetis, C., Diedrich, K., & Tarlatzis, B. (2010). Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotrophin-releasing hormone antagonist cycles: an updated meta-analysis. Fertility & Sterility, 94, 2382–2384.
   PubMed Web of Science ®Google Scholar
• Groeneveld, E., Broeze, K.A., Lambers, M.J., Haapsamo, M., Dirckx, K., Schoot, B.C., et al.; IPD MARIA study group. (2011). Is aspirin effective in women undergoing in vitro fertilization (IVF)? Results from an individual patient data meta-analysis (IPD MA). Human Reproduction Update, 17, 501–509.
   PubMed Web of Science ®Google Scholar
• Groeneveld, E., Lambers, M.J., Lambalk, C.B., Broeze, K.A., Haapsamo, M., de Sutter, P., et al. (2013). Preconceptional low-dose aspirin for the prevention of hypertensive pregnancy complications and preterm delivery after IVF: a meta- analysis with individual patient data. Human Reproduction, 28, 1480–1488.
   PubMed Web of Science ®Google Scholar
• Harper, K., Proctor, M., & Hughes, E. (2003). Growth hormone for in vitro fertilization. Cochrane Database of Systematic Reviews, 3, CD000099.
   Google Scholar
• Hasegawa, I., Yamanoto, Y., Suzuki, M., Murakawa, H., Kurabayashi, T., Takakuwa, K., & Tanaka, K. (1998). Prednisolone plus low-dose aspirin improves the implantation rate in women with autoimmune conditions who are undergoing in vitro fertilization. Fertility & Sterility, 70, 1044–1048.
   PubMed Web of Science ®Google Scholar
• Heilmann, L., Schorsch, M., & Hahn, T. (2010). CD3-CD56 + CD16+ natural killer cells and improvement of pregnancy outcome in IVF/ICSI failure after additional IVIG-treatment. American Journal of Reproductive Immunology, 63, 263–265.
   PubMed Web of Science ®Google Scholar
• Hillier, S.G. & Tetsuka, M. (1997). Role of androgens in follicle maturation and atresia. Baillieres Clinical Obstetrics and Gynaecology, 11, 249–260.
   PubMed Web of Science ®Google Scholar
• Homburg, R. & Ostergaard, H. (1995). Clinical applications of growth hormone for ovarian stimulation. Human Reproduction Update, 1, 264–275.
   PubMed Web of Science ®Google Scholar
• Howles, C.M., Loumaye, E., Germond, M., Yates, R., Brinsden, P., Healy, D., et al. (1999). Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization? Human Reproduction, 14, 1939–1943.
   PubMed Web of Science ®Google Scholar
• Huirne, J.A., Hugues, J.N., Pirard, C., Fischl, F., Sage, J.C., Pouly, J.L., et al. (2006). Cetrorelix in an oral contraceptive-pretreated stimulation cycle compared with buserelin in IVF/ICSI patients treated with r-hFSH: a randomized, multicenter, phase IIIb study. Human Reproduction, 21, 1408–1415.
   PubMed Web of Science ®Google Scholar
• Hutchinson-Williams, K.A., Lunenfeld, B., Diamond, M.P., Lavy, G., Boyers, S.P., & DeCherney, A.H. (1989). Human chorionic gonadotropin, estradiol, and progesterone profiles in conception and non-conception cycles in an in vitro fertilization program. Fertility & Sterility, 52, 441–445.
   PubMed Web of Science ®Google Scholar
• IVF Worldwide Survey. (2010). Poor responders. How to define diagnose and treat. www.ivf-worldwide.com/survey/poor-responders/ results-poor responders.html. Last access Jan 2014.
   Google Scholar
• Jee, B.C., Suh, C.S., Kim, S.H., Kim, Y.B., & Moon, S.Y. (2010). Effects of estradiol supplementation during the luteal phase of in vitro fertilization cycles: a meta-analysis. Fertility & Sterility, 93, 428–436.
   PubMed Web of Science ®Google Scholar
• Jerzak, M., Niemiec, T., Nowakowska, A., Klochowicz, M., Górski, A., & Baranowski, W. (2010). First successful pregnancy after addition of enoxaparin to sildenafil and etanercept immunotherapy in woman with fifteen failed IVF cycles - case report. American Journal of Reproductive Immunology, 64, 93–96.
   PubMed Web of Science ®Google Scholar
• Kalu, E., Bhaskaran, S., Thum, M.Y., Vishwanatha, R., Croucher, C., Sherriff, E., et al. (2008). Serial estimation of Th1:th2 cytokines profile in women undergoing in-vitro fertilization-embryo transfer. American Journal of Reproductive Immunology, 59, 206–211.
   PubMed Web of Science ®Google Scholar
• Kara, M., Aydin, T., Aran, T., Turktekin, N., & Ozdemir, B. (2014). Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve? European Journal of Obstetrics & Gynecolology and Reproductive Biology, 173, 63–65.
   PubMed Web of Science ®Google Scholar
• Khairy, M., Banerjee, K., El-Toukhy, T., Coomarasamy, A., & Khalaf, Y. (2007). Aspirin in women undergoing in vitro fertilization treatment: a systematic review and meta-analysis. Fertility & Sterility, 88, 822–831.
   PubMed Web of Science ®Google Scholar
• Kim, C.H., Chae, H.D., & Chang, Y.S. (1999). Pyridostigmine cotreatment for controlled ovarian hyperstimulation in low responders undergoing in vitro fertilization-embryo transfer. Fertility & Sterility, 71, 652–657.
   PubMed Web of Science ®Google Scholar
• Kolibianakis, E.M., Venetis, C.A., Diedrich, K., Tarlatzis, B.C., & Griesinger, G. (2009). Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis. Human Reproduction Update, 15, 613–622.
   PubMed Web of Science ®Google Scholar
• Kolibianakis, E.M., Venetis, C.A., & Tarlatzis, B.C. (2011). DHEA administration in poor responders. Human Reproduction, 26, 730–731.
   PubMed Web of Science ®Google Scholar
• Kucuk, T., Kozinoglu, H., & Kaba, A. (2008). Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics, 25, 123–127.
   PubMed Web of Science ®Google Scholar
• Kutteh, W.H., Yetman, D.L., Chantilis, S.J., & Crain, J. (1997). Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: role of heparin and aspirin. Human Reproduction, 2, 1171–1175.
   Google Scholar
• Kwak-Kim, J., Han, A.R., Gilman-Sachs, A., Fishel, S., Leong, M., & Shoham, Z. (2013). Current trends of reproductive immunology practices in in vitro fertilization (IVF) - a first world survey using IVF-Worldwide.com. American Journal of Reproductive Immunology, 69, 12–20.
   PubMed Web of Science ®Google Scholar
• Kwon, S.K., Kim, C.H., Lee, K.H., Jeon, I.K., Ahn, J.W., Kim, S.H., et al. (2013). Luteal estradiol supplementation in gonadotropin-releasing hormone antagonist cycles for infertile patients in vitro fertilization. Clinicaland Experimental Reproductive Medicine, 40, 131–134.
   PubMedGoogle Scholar
• Lesny, P., Killick, S.R., Tetlow, R.L., Robinson, J., & Maguiness, S.D. (1998). Uterine junctional zone contractions during assisted reproduction cycles. Human Reproduction Update, 4, 440–445.
   PubMed Web of Science ®Google Scholar
• Li, J., Chen, Y., Liu, C., Hu, Y., & Li, L. (2013). Intravenous immunoglobulin treatment for repeated IVF/ICSI failure and unexplained infertility: a systematic review and a meta-analysis. American Journal of Reproductive Immunology, 70, 434–447.
   PubMed Web of Science ®Google Scholar
• Lin, H., Li, Y., Li, L., Wang, W., Zhang, Q., Chen, X., & Yang, D. (2013). Oral oestradiol supplementation as luteal support in IVF/ICSI cycles: a prospective, randomized controlled study. European Journal of Obstetrics & Gynecology and Reproductive Biology, 167, 171–175.
   PubMed Web of Science ®Google Scholar
• Linhardt, R.J., Wang, H.M., & Ampofo, S.A. (1992). New methodologies in heparin structure analysis and the generation of LMW heparins. Advances in Experimental Medicine and Biology, 313, 37–47.
   PubMedGoogle Scholar
• Lukaszuk, K., Liss, J., Lukaszuk, M., & Maj, B. (2005). Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles. Fertility & Sterility, 83, 1372–1376.
   PubMed Web of Science ®Google Scholar
• Ma, C.H., Yan, L.Y., Qiao, J., Sha, W., Li, L., Chen, Y., & Sun, Q.Y. (2010). Effects of tumor necrosis factor-alpha on porcine oocyte meiosis progression, spindle organization, and chromosome alignment. Fertility & Sterility, 93, 920–926.
   PubMed Web of Science ®Google Scholar
• Mendoza, C., Cremades, N., Ruiz-Requena, E., Martinez, F., Ortega, E., Bernabeu, S., & Tesarik, J. (1999). Relationship between fertilization results after intracytoplasmic sperm injection, and intrafollicular steroid, pituitary hormone and cytokine concentrations. Human Reproduction, 14, 628–635.
   PubMed Web of Science ®Google Scholar
• Mendoza, C., Ruiz-Requena, E., Ortega, E., Cremades, N., Martinez, F., Bernabeu, R., et al. (2002). Follicular fluid markers of oocyte developmental potential. Human Reproduction, 17, 1017–1022.
   PubMed Web of Science ®Google Scholar
• Ménézo, Y., Dale, B., & Cohen, M. (2010). DNA damage and repair in human oocytes and embryos: a review. Zygote, 18, 357–365.
   PubMed Web of Science ®Google Scholar
• Moraru, M., Carbone, J., Alecsandru, D., Castillo-Rama, M., García-Segovia, A., Gil, J., et al. (2012). Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells. American Journal of Reproductive Immunology, 68, 75–84.
   PubMed Web of Science ®Google Scholar
• Morizaki, N., Morizaki, J., Hayashi, R.H., & Garfield, R.E. (1989). A functional and structural study of the innervation of the human uterus. American Journal of Obstetrics & Gynecology, 160, 218–228.
   PubMed Web of Science ®Google Scholar
• Nardo, L.G., Granne, I., & Stewart, J. (2009). Policy and Practice Committee of the British Fertility Society. Medical adjuncts in IVF: evidence for clinical practice. Human Fertility, 12, 1–13.
   PubMed Web of Science ®Google Scholar
• Nardo, L.G., Bosch, E., Lambalk, C.B, & Gelbaya, T.A. (2013). Controlled ovarian hyperstimulation regimens: a review of the available evidence for clinical practice. Produced on behalf of the BFS Policy and Practice Committee. Human Fertility, 16, 144–150.
   Google Scholar
• Narkwichean, A., Maalouf, W., Campbell, B.K., & Jayaprakasan, K. (2013). Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis. Reproductive Biology and Endocrinology, 16, 11:44.
   Google Scholar
• Narkwichean, A., Jayaprakasan, K., Maalouf, W.E., Hernandez-Medrano, J.H., Pincott-Allen, C., & Campbell, B.K. (2014). Effects of dehydroepiandrosterone on in vivo ovine follicular development. Human Reproduction, 29, 146–154.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence (NICE). (2004). Fertility: assessment and treatment for people with fertility problems. Clinical Guideline, CG11, 1.12.3.
   Google Scholar
• National Institute for Health and Clinical Excellence (NICE). (2013). Fertility: assessment and treatment for people with fertility problems. Clinical Guideline, CG156, 1.12.4.
   Google Scholar
• Nduwke, G. (2011). Recurrent embryo implantation failure after in vitro fertilization: improved outcome following intralipid infusion in women with elevated T helper 1 response. Human Fertility, 14, 21–22.
   Google Scholar
• Nielsen, M.E., Rasmussen, I.A., Kristensen, S.G., Christensen, S.T., Møllgård, K., Wreford Andersen, E., et al. (2011). In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA. Molecular Human Reproduction, 17, 63–70.
   PubMed Web of Science ®Google Scholar
• Noci, I., Milanini, M.N., Ruggiero, M., Papini, F., Fuzzi, B., & Artini, P.G. (2011). Effect of dalteparin sodium administration on IVF outcome in non-thrombophilic young women: a pilot study. Reproductive Biomedicine Online, 22, 615–620.
   PubMed Web of Science ®Google Scholar
• Ohl, J., Lefèbvre-Maunoury, C., Wittemer, C., Nisand, G., Laurent, M.C., & Hoffmann, P. (2002). Nitric oxide donors for patients undergoing IVF. A prospective, double-blind, randomized, placebo-controlled trial. Human Reproduction, 17, 2615–2620.
   PubMed Web of Science ®Google Scholar
• Okazaki, M., Matsuyama, T., Kohno, T., Shindo, H., Koji, T., Morimoto, Y., & Ishimaru, T. (2005). Induction of epithelial cell apoptosis in the uterus by a mouse uterine ischemia-reperfusion model: possible involvement of tumor necrosis factor-alpha. Biology of Reproduction, 72, 1282–1288.
   PubMed Web of Science ®Google Scholar
• Owen, E.J., Ostergaard, H., Shoham, Z., Jacobs, H.S., & Mason, B.A. (1991). Co-treatment with growth hormone, after pituitary suppression, for ovarian stimulation in in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertility & Sterility, 56, 1104–1110.
   PubMed Web of Science ®Google Scholar
• Palabrica, F.R., Kwong, S.L., & Padua, F.R. (2013). Adverse events of intravenous immunoglobulin infusions: a ten-year retrospective study. Asia Pacific Allergy, 3, 249–256.
   PubMedGoogle Scholar
• Palomba, A., Falbo, A., Orio, F. Jr., & Zullo F. (2009). Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Fertility & Sterility, 92, 1646–1658.
   PubMed Web of Science ®Google Scholar
• Patrono, C., García Rodríguez, L.A., Landolfi, R., & Baigent, C. (2005). Low-dose aspirin for the prevention of atherothrombosis. New England Journal of Medicine, 353, 2373–2383.
   PubMed Web of Science ®Google Scholar
• Pinheiro, O.L., Cavagna, M., Baruffi, R.L., Mauri, A.L., Petersen, C., & Franco, J.G. Jr. (2003). Administration of beta2-adrenergic agonists during the peri-implantation period does not improve implantation or pregnancy rates in intracytoplasmic sperm injection (ICSI) cycles. Journal of Assisted Reproduction and Genetics, 20, 513–516.
   PubMed Web of Science ®Google Scholar
• Pitteloud, N., Mootha, V.K., Dwyer, A.A., Hardin, M., Lee, H., Eriksson, K.F., et al. (2005). Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care, 28, 1636–1642.
   PubMed Web of Science ®Google Scholar
• Polanski, L.T., Barbosa, M.A., Martins, W.P., Baumgarten, M.N., Campbell, B., Brosens, J., et al. (2014). Interventions to improve reproductive outcomes in women with elevated natural killer cells undergoing assisted reproduction techniques: a systematic review of literature. Human Reproduction, 29, 65–75.
   PubMed Web of Science ®Google Scholar
• Potdar, N., Gelbaya, T.A., Konje, J.C., & Nardo, L.G. (2013). Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis. Human Reproduction Update, 19, 674–684.
   PubMed Web of Science ®Google Scholar
• Poustie, V., Dodd, S., & Drakeley, A. (2007). Low dose aspirin for in vitro fertilisation. Cochrane Database of Systematic Reviews, 17, CD004832.
   Google Scholar
• Qublan, H.S., Eid, S.S., Ababneh, H.A., Amarin, Z.O., Smadi, A.Z., Al-Khafaji, F.F., & Khader, Y.S. (2006). Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Human Reproduction, 21, 2694–2698.
   PubMed Web of Science ®Google Scholar
• Qublan, H., Amarin, Z., Dabbas, M., Farraj, A.E., Beni-Merei, Z., Al-Akash, H., et al. (2008). Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial. Human Fertility, 11, 246–253.
   PubMedGoogle Scholar
• Revelli, A., Casano, S., Piane, L.D., Grassi, G., Gennarelli, G., Guidetti, D., & Massobrio, M. (2009). A retrospective study on IVF outcome in euthyroid patients with anti-thyroid antibodies: effects of levothyroxine, acetyl-salicylic acid and prednisolone adjuvant treatments. Reproductive Biology and Endocrinology, 7, 137.
   PubMed Web of Science ®Google Scholar
• Rogolino, A., Coccia, M.E., Fedi, S., Gori, A.M., Cellai, A.P., Scarselli, G.F., et al. (2003). Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome. Blood Coagulation & Fibrinolysis, 14, 277–282.
   PubMed Web of Science ®Google Scholar
• Ruopp, M.D., Collins, T.C., Whitcomb, B.W., & Schisterman, E.F. (2008). Evidence of absence or absence of evidence?A reanalysis of the effects of low-dose aspirin in in vitro fertilization. Fertility & Sterility, 90, 71–76.
   PubMed Web of Science ®Google Scholar
• Roussev, R.G., Acacio, B., Ng, S.C., & Coulam, C.B. (2008). Duration of intralipid‘s suppressive effect on NK cell's functional activity. American Journal of Reproductive Immunology, 60, 258–263.
   PubMed Web of Science ®Google Scholar
• Schenk, L.M., Morris, J.P., Cox, B., Lecte, J., Abuhamed, A., Ochninger, S., et al. (1996). Heparin and aspirin treatment yields higher implantation rates in IVF patients with antiphospholipid antibodies seropositivity compared to untreated seronegative patients (abstract). Proceedings of the Annual Meeting of the American Society of Reproductive Medicine, Boston, USA.
   Google Scholar
• Sengupta, J., Dhawan, L., Lalitkumar, P.G., & Ghosh, D. (2005). Nitric oxide in blastocyst implantation in rhesus monkey. Reproduction, 130, 321–332.
   PubMed Web of Science ®Google Scholar
• Seshadri, S., Sunkara, S.K., Khalaf, Y., El-Toukhy, T., & Hamoda, H. (2012). Effect of heparin on the outcome of IVF treatment: a systematic review and meta-analysis. Reproductive Biomedicine Online, 25, 572–584.
   PubMed Web of Science ®Google Scholar
• Shaker, A.G., Fleming, R., Jamieson, M.E., Yates, R.W., & Coutts, J.R. (1993). Assessments of embryo transfer after in-vitro fertilization: effects of glyceryl trinitrate. Human Reproduction, 8, 1426–1428.
   PubMed Web of Science ®Google Scholar
• Sher, G., Feinman, M., Zouves, C., Kuttner, G., Maassarani, G., Salem, R., et al. (1994). High fecundity rates following invitro fertilization and embryo transfer in antiphospholipid antibodyseropositive women treated with heparin and aspirin. Human Reproduction, 9, 2278–2283.
   PubMed Web of Science ®Google Scholar
• Sher, G., Matzner, W., Feinman, M., Maassarani, G., Zouves, C., Chong, P., & Ching, W. (1998). The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. American Journal of Reproductive Immunology, 40, 74–82.
   PubMed Web of Science ®Google Scholar
• Sher, G., & Fisch, J.D. (2000). Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Human Reproduction, 15, 806–809.
   PubMed Web of Science ®Google Scholar
• Sher, G., & Fisch, JD. (2002). Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertility & Sterility, 78, 1073–1076.
   PubMed Web of Science ®Google Scholar
• Siristatidis, C.S., Dodd, S.R., & Drakeley, A.J. (2011). Aspirin for in vitro fertilisation. Cochrane Database of Systematic Reviews, 8, CD004832.
   Google Scholar
• Siristatidis, C., Chrelias, C., Creatsas, M., Varounis, C., Vrachnis, N., Iliodromiti, Z., & Kassanos, D. (2013). Addition of prednisolone and heparin in patients with failed IVF/ICSI cycles: a preliminary report of a clinical trial. Human Fertility, 16, 207–210.
   PubMed Web of Science ®Google Scholar
• Smitz, J., Bourgain, C., van Waesberghe, L., Camus, M., Devroey, P., & van Steirteghem, A.C. (1993). A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation. Human Reproduction, 8, 40–45.
   PubMed Web of Science ®Google Scholar
• Smulders, B., van Oirschot, S.M., Farquhar, C., Rombauts, L., & Kremer, J.A.M. (2010). Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. Cochrane Database of Systematic Reviews, 1, CD006109.
   Google Scholar
• Souayah, N., Hasan, A., Khan, H.M., Yacoub, H.A., & Jafri, M. (2011). The safety profile of home infusion of intravenous immunoglobulin in patients with neuroimmunologic disorders. Journal of Clinical Neuromuscular Disease, 12, S1–S10.
   PubMedGoogle Scholar
• Spiliotis, B.E. (2003). Growth hormone insufficiency and its impact on ovarian function. Annals of the New York Academy of Sciences, 997, 77–84.
   PubMed Web of Science ®Google Scholar
• Stern, C., Chamley, L., Norris, H., Hale, L., & Baker, H.W. (2003). A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertility & Sterility, 80, 376–383.
   PubMed Web of Science ®Google Scholar
• Suikkari, A.M., MacLachlan, V., Koistinen, R., Seppälä, M., & Healy, D.L. (1996). Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertility & Sterility, 65, 800–805.
   PubMed Web of Science ®Google Scholar
• Sunkara, S.K., Pundir, J., & Khalaf, Y. (2011). Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis. Reproductive Biomedicine Online, 22, 545–555.
   PubMed Web of Science ®Google Scholar
• Swanton, A., Lighten, A., Granne, I., McVeigh, E., Lavery, S., et al. (2011). Do women with ovaries of polycystic morphology without any other features of PCOS benefit from short-term metformin co-treatment during IVF? A double-blind, placebo-controlled, randomized trial. Human Reproduction, 26, 2178–2184.
   PubMed Web of Science ®Google Scholar
• Takasaki, A., Tamura, H., Miwa, I., Taketani, T., Shimamura, K., & Sugino, N. (2010). Endometrial growth and uterine blood flow: a pilot study for improving endometrial thickness in the patients with a thin endometrium. Fertility & Sterility, 93, 1851–1858.
   PubMed Web of Science ®Google Scholar
• Tamada, H., Higashiyama, C., Takano, H., Kawate, N., Inaba, T., & Sawada, T. (1999). The effects of heparin-binding epidermal growth factor-like growth factor on preimplantation-embryo development and implantation in the rat. Life Science, 64, 1967–1973.
   PubMed Web of Science ®Google Scholar
• Tang, T., Glanville, J., Orsi, N., Barth, J.H., & Balen AH. (2006). The use of metformin for women with PCOS undergoing IVF treatment. Human Reproduction, 21, 1416–1425.
   PubMed Web of Science ®Google Scholar
• Tang, T., Lord, J.M., Norman, R.J., Yasmin, E., & Balen, A.H. (2012). Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, Dchiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database of Systematic Reviews, 5, CD003053.
   Google Scholar
• Taniguchi, F. (2005). Results of Prednisolone given to improve the outcome of in vitro fertilization-embryo transfer in women with anti-nuclear antibodies. Journal of Reproductive Medicine, 50, 383–388.
   PubMed Web of Science ®Google Scholar
• Tay, P.Y., & Lenton, E.A. (2003). Inhibition of progesterone secretion by oestradiol administered in the luteal phase of assisted conception cycles. Medical Journal of Malaysia, 58, 187–195.
   PubMedGoogle Scholar
• Telfer, J.F., Irvine, G.A., Kohnen, G., Campbell, S., & Cameron, I.T. (1997). Expression of endothelial and inducible nitric oxide synthase in non-pregnant and decidualized human endometrium. Molecular Human Reproduction, 3, 69–75.
   PubMed Web of Science ®Google Scholar
• Tesarik, J., Hazout, A., & Mendoza, C. (2005). Improvement of delivery and live birth rates after ICSI in women aged > 40 years by ovarian co-stimulation with growth hormone. Human Reproduction, 20, 2536–2541.
   PubMed Web of Science ®Google Scholar
• The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, Thessaloniki, Greece; Tarlatzis, B.C., Fauser, J.M., Chang, J., Franks, S., Legro, R., Rebar, R.W., et al. (2008). Consensus on infertility treatment related to polycystic ovary syndrome. Human Reproduction, 23: 462–477.
   PubMed Web of Science ®Google Scholar
• Thum, M.Y., Abdalla, H.I., Bhaskaran, S., Harden, E.L., Ford, B., Sumar, N., et al. (2007). The relationship of systemic TNF-alpha and IFN-gamma with IVF treatment outcome and peripheral blood NK cells. American Journal of Reproductive Immunology, 57, 210–217 .***
   PubMed Web of Science ®Google Scholar
• Tonguc, E., Var, T., Ozyer, S., Citil, A., & Dogan, M. (2011). Estradiol supplementation during the luteal phase of in vitro fertilization cycles: a prospective randomised study. European Journal of Obstetrics & Gynecology and Reproductive Biology, 154, 172–176.
   PubMed Web of Science ®Google Scholar
• Tso, L.O., Costello, M.F., Albuquerque, L.E., Andriolo, R.B., & Freitas, V. (2009). Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews, 2, CD006105.
   Google Scholar
• Urman, B., Ata, B., Yakin, K., Alatas, C., Aksoy, S., Mercan, R., & Balaban, B. (2009). Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial. Human Reproduction, 24, 1640–1647.
   PubMed Web of Science ®Google Scholar
• van Gestel, I., IJland, M.M., Hoogland, H.J., & Evers, J.L. (2003). Endometrial wave-like activity in the non-pregnant uterus. Human Reproduction Update, 9, 131–138.
   PubMed Web of Science ®Google Scholar
• Vane, J.R., Flower, R.J., & Botting, R.M. (1990). History of aspirin and its mechanism of action. Stroke, 21, 12–23.
   Web of Science ®Google Scholar
• Vanky, E., Stridsklev, S., Heimstad, R., Romundstad, P., Skogoy, K., Kleggetveit, O., et al. (2010). Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. Journal of Clinical Endocrinology & Metabolism, 95, 448–455.
   PubMed Web of Science ®Google Scholar
• Virro, M.R., Winger, E.E., & Reed, J.L. (2012). Intravenous immunoglobulin for repeated IVF failure and unexplained infertility. American Journal of Reproductive Immunology, 68, 218–225.
   PubMed Web of Science ®Google Scholar
• Wada, I., Hsu, C.C., Williams, G., Macnamee, M.C., & Brinsden, P.R. (1994). The benefits of low-dose aspirin therapy in women with impaired uterine perfusion during assisted conception. Human Reproduction, 9, 1954–1957.
   PubMed Web of Science ®Google Scholar
• Walters, K.A., Allan, C.M., & Handelsman, D.J. (2008). Androgen actions and the ovary. Biology of Reproduction, 78, 380–389.
   PubMed Web of Science ®Google Scholar
• Walters, K.A., Simanainen, U., & Handelsman, D.J. (2010). Molecular insights into androgen actions in male and female reproductive function from androgen receptor knockout models. Human Reproduction Update, 16, 543–558.
   PubMed Web of Science ®Google Scholar
• Winger, E.E., Reed, J.L., Ashoush, S., Ahuja, S., El-Toukhy, T., & Taranissi, M. (2009). Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. American Journal of Reproductive Immunology, 61, 113–120.
   PubMed Web of Science ®Google Scholar
• Winger, E.E., Reed, J.L., Ashoush, S., El-Toukhy, T., Ahuja, S., & Taranissi, M. (2011a). Elevated preconception CD56 + 16+ and/or Th1:Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF. American Journalof Reproductive Immunology, 66, 394–403.
   PubMed Web of Science ®Google Scholar
• Winger, E.E., Reed, J.L., Ashoush, S., El-Toukhy, T., Ahuja, S., & Taranissi, M. (2011b). Degree of TNF-α/IL-10 cytokine elevation correlates with IVF success rates in women undergoing treatment with Adalimumab (Humira) and IVIG. American Journal of Reproductive Immunology, 65, 610–618.
   PubMed Web of Science ®Google Scholar
• Winger, E.E., Reed, J.L., Ashoush, S., El-Toukhy, T., & Taranissi M. (2012). Die-off ratio correlates with increased TNF-α:IL-10 ratio and decreased IVF success rates correctable with humira. American Journal of Reproductive Immunology, 68, 428–437.
   PubMed Web of Science ®Google Scholar
• Wiser, A., Gonen, O., Ghetler, Y., Shavit, T., Berkovitz, A., & Shulman, A. (2010). Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Human Reproduction, 25, 2496–2500.
   PubMed Web of Science ®Google Scholar
• Yakin, K., & Urman, B. (2011). DHEA as a miracle drug in the treatment of poor responders; hype or hope? Human Reproduction, 26, 1941–1944.
   PubMed Web of Science ®Google Scholar
• Yilmaz, N., Uygur, D., Inal, H., Gorkem, U., Cicek, N., & Mollamahmutoglu, L. (2013). Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count. European Journal of Obstetrics & Gynecology and Reproductive Biology, 169, 257–260.
   PubMed Web of Science ®Google Scholar
• Ying, Y., Zhong, Y.P., Zhou, C.Q., Xu, Y.W., Wang, Q., Li, J, et al. (2012). A retrospective study on IVF outcome in patients with anticardiolipin antibody: effects of methylprednisolone plus low-dose aspirin adjuvant treatment. Journal of Reproductive Immunology, 94, 196–201.
   PubMed Web of Science ®Google Scholar
• Zhang, X., Wang, H.M., Lin, H.Y., Liu, G.Y., Li, Q.L., & Zhu, C. (2004). Regulation of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) during mouse peri-implantation: role of nitric oxide. Placenta, 25, 243–252.
   PubMed Web of Science ®Google Scholar